Negative Controls in PCR and qPCR: Why They Matter and How to Set Them Up

Negative controls are essential components of every polymerase chain reaction (PCR) and quantitative PCR (qPCR) experiment, serving as the primary safeguard against false-positive results caused by contamination, nonspecific amplification, or reagent carryover. A negative control is a reaction that contains all components of the master mix except the target nucleic acid template, and it should produce no detectable amplification signal. When a negative control yields a positive result, it indicates contamination or reagent failure, invalidating the entire experimental run. These controls are useful in virtually all PCR-based applications, including endpoint PCR, real-time qPCR, reverse transcription PCR (RT-PCR), and digital PCR, and they are mandatory for publication-quality data and reproducible research.

At a Glance

Scientific Principle: Why Negative Controls Work

The fundamental principle behind negative controls is straightforward: if amplification occurs in a reaction that lacks template DNA or RNA, the signal must originate from an unintended source. PCR is an exponential amplification process, meaning that even a single contaminating molecule can be amplified to detectable levels within 30–40 cycles. Negative controls exploit this sensitivity to reveal contamination that might otherwise go unnoticed.

The no-template control (NTC) operates on the principle that all reagents, plasticware, and laboratory environment should be free of amplifiable nucleic acids. When the template is replaced with nuclease-free water, any amplification product must arise from contaminating DNA or RNA introduced during master mix preparation, pipetting, or from the reagents themselves. This is particularly critical in qPCR, where the fluorescence-based detection system can detect amplification from as few as 1–10 template copies.

For reverse transcription PCR (RT-PCR) applications, the no-reverse-transcriptase control (NRT) serves a different but equally important purpose. The NRT contains RNA template but lacks reverse transcriptase enzyme. If amplification occurs in this control, it indicates that the signal originates from contaminating genomic DNA rather than from the intended RNA target. This distinction is crucial for gene expression studies where the presence of genomic DNA can produce misleading results.

Materials and Reagent Considerations

Water Quality

The choice of water for negative controls is critical. Nuclease-free water is the standard, but not all commercially available nuclease-free water is equivalent. For PCR and qPCR applications, water should be certified DNase/RNase-free and tested for the absence of amplifiable nucleic acids. Some laboratories use DEPC-treated water, but this is primarily for RNA work and must be autoclaved to remove residual DEPC before use in PCR.

Master Mix Components

Commercial master mixes vary in their susceptibility to contamination. Some contain uracil-DNA glycosylase (UDG) systems that degrade contaminating dU-containing amplicons, providing an additional layer of protection. However, these systems do not eliminate the need for negative controls. When using custom master mixes, each component should be tested individually for contamination by running a negative control that includes that component alone.

Plasticware and Pipettes

Dedicated PCR-grade filter tips are essential for preparing negative controls. Standard non-filter tips can introduce aerosol contamination during pipetting. Pipettes used for PCR setup should be dedicated to pre-amplification work and never used for handling post-amplification products. The use of separate pipettes for master mix preparation versus sample addition is a recommended practice.

Types of Negative Controls

No Template Control (NTC)

The NTC is the most common negative control and is required for every PCR and qPCR run. It contains all components of the reaction mixture except the template nucleic acid, which is replaced with an equal volume of nuclease-free water. The NTC should be placed in at least one well per plate or tube strip, and ideally in duplicate or triplicate for qPCR experiments.

When to use: Every PCR and qPCR run, regardless of application.

Expected result: No amplification (Ct > 35–40 for qPCR, no visible band for endpoint PCR).

No Reverse Transcriptase Control (NRT)

The NRT is specific to RT-PCR and RT-qPCR experiments. It contains RNA template and all RT-PCR components except the reverse transcriptase enzyme. This control detects amplification from contaminating genomic DNA that may be present in the RNA preparation.

When to use: Any experiment involving reverse transcription, including gene expression studies, viral RNA detection, and RNA-seq validation.

Expected result: No amplification or significantly delayed Ct compared to the experimental samples.

No Enzyme Control (NEC)

The NEC is a broader control that omits a key enzyme from the reaction, such as DNA polymerase in PCR or reverse transcriptase in RT-PCR. This control is useful when troubleshooting new protocols or when testing new reagent lots. It can help distinguish between contamination and nonspecific enzyme activity.

When to use: When validating new reagents, troubleshooting unexpected amplification, or establishing new protocols.

Expected result: No amplification.

Extraction Blank

While not strictly a PCR control, the extraction blank is a critical negative control that undergoes the entire nucleic acid extraction process using water or buffer instead of sample. This control detects contamination introduced during extraction, which can then carry over into the PCR.

When to use: Any experiment involving nucleic acid extraction, particularly when working with low-template samples.

Expected result: No amplification after PCR.

Conceptual Workflow for Setting Up Negative Controls

Step 1: Prepare Master Mix

Prepare the master mix in a dedicated pre-amplification area (clean room or PCR hood) that is physically separated from post-amplification work. Include all components except template. For NTC reactions, the master mix volume should account for the water that will replace the template.

Step 2: Dispense Master Mix

Aliquot the master mix into tubes or plate wells. For NTC wells, add the appropriate volume of nuclease-free water. For NRT controls, add the master mix without reverse transcriptase, then add RNA template.

Step 3: Add Template

Add template DNA or cDNA to experimental wells. Use a fresh filter tip for each sample to prevent cross-contamination. The negative control wells should receive no template.

Step 4: Seal and Centrifuge

Seal the plate or tubes with optical adhesive film or caps. Centrifuge briefly to collect contents at the bottom and remove air bubbles.

Step 5: Run the Reaction

Place the plate or tubes in the thermal cycler and run the appropriate protocol. For qPCR, ensure that the instrument is programmed to collect fluorescence data for all wells, including negative controls.

Step 6: Analyze Results

Examine the amplification curves and Ct values for all negative controls. Any amplification signal in the NTC indicates contamination and requires investigation before experimental results can be interpreted.

Quality Checks and Acceptance Criteria

For qPCR

• NTC Ct value: Should be > 35 or undetermined. A Ct value of 35–38 may indicate low-level contamination and warrants investigation.
• Melt curve analysis: If amplification is observed in NTC, examine the melt curve. A melt peak identical to the target amplicon suggests specific contamination. A different melt peak may indicate primer-dimer or nonspecific amplification.
• Replicate consistency: NTC replicates should show no amplification. If one replicate amplifies but others do not, it suggests sporadic contamination during setup.

For Endpoint PCR

• Gel electrophoresis: No visible band in the NTC lane at the expected product size.
• Primer-dimer bands: Small, diffuse bands below 100 bp may appear in NTC lanes due to primer-dimer formation. These are acceptable if they do not interfere with interpretation of experimental samples.

For RT-qPCR

• NRT control: Should show no amplification or a Ct at least 5–10 cycles higher than the experimental samples. A similar Ct between NRT and experimental samples indicates genomic DNA contamination.

Result Interpretation

Negative Control Passes (No Amplification)

When the negative control shows no amplification, the experimental results can be interpreted with confidence that contamination is not a confounding factor. This does not guarantee that all samples are contamination-free, but it indicates that the reagents and setup process are clean.

Negative Control Fails (Amplification Detected)

A failed negative control requires immediate action. The entire run should be considered potentially compromised, and experimental results should not be reported or used for publication. The following steps should be taken:

1. Identify the source: Check all reagents, water, and plasticware. Replace each component systematically.
2. Repeat the run: After identifying and correcting the contamination source, repeat the entire experiment with fresh reagents and new negative controls.
3. Document the failure: Record the Ct value, melt curve, and any observations in the laboratory notebook.

Borderline Results

Sometimes the NTC shows very late amplification (Ct 36–38 in a 40-cycle run). This can be caused by:

• Primer-dimer formation (check melt curve)
• Low-level contamination
• Instrument artifacts

In such cases, the melt curve is the best discriminator. If the melt peak matches the target, contamination is likely. If it is different, primer-dimer or nonspecific amplification is more probable.

Troubleshooting Table

Limitations and Edge Cases

What Negative Controls Cannot Detect

Negative controls are powerful but have limitations. They cannot detect:

• Cross-contamination during sample preparation: If a sample contaminates another sample during extraction or pipetting, the NTC will remain clean because it was not exposed to the contaminated sample.
• Inhibition: Negative controls do not contain template, so they cannot reveal PCR inhibition in experimental samples.
• Sample-specific contamination: If only certain samples contain inhibitors or contaminants that affect amplification, the NTC will not reflect this.

Edge Cases

• High-throughput screening: In 384-well plates, placing NTCs in corner wells may miss contamination that occurs in the center of the plate. Distribute NTCs across the plate.
• Multiplex PCR: Each target in a multiplex reaction requires its own NTC interpretation. One target may show contamination while others remain clean.
• Digital PCR: Negative controls in digital PCR should show zero positive partitions. Even one positive partition in the NTC indicates contamination.

Documentation Best Practices

Proper documentation of negative control results is essential for reproducibility and publication. For every PCR or qPCR run, record the following:

• Run date and operator
• Instrument used and protocol version
• Master mix lot number and expiration date
• Water lot number
• Primer and probe lot numbers
• NTC Ct values for each replicate
• Melt curve analysis results (for qPCR)
• Gel image (for endpoint PCR)
• Any observations or deviations from protocol

Many journals now require that negative control data be included in supplementary materials. The Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines explicitly require reporting of NTC results.

Biosafety Considerations

While negative controls for PCR and qPCR typically involve non-infectious materials (nuclease-free water, purified nucleic acids), the biosafety context of the experimental samples must be considered. According to the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition, risk assessment should guide the handling of all biological materials, including controls [1].

For BSL-1 routine work:

• Negative controls can be prepared on the open bench if using dedicated PCR-grade reagents and filter tips
• All waste should be disposed of according to institutional biosafety guidelines
• Work surfaces should be decontaminated before and after PCR setup

For work with recombinant or synthetic nucleic acids, the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules require that appropriate containment practices be followed, including the use of biological safety cabinets when handling potentially hazardous materials [2].

The NCBI Bookshelf provides comprehensive molecular biology methods references that include detailed protocols for PCR setup and control implementation [3].

Frequently Asked Questions

1. Can I use the same negative control for multiple PCR runs?

No. Each PCR run requires its own negative control prepared fresh with the reagents used in that run. Reusing a negative control from a previous run does not account for contamination that may have been introduced during the current setup.

2. My NTC shows a band on the gel but it's a different size than my target. Is this acceptable?

A band of different size in the NTC is often primer-dimer or nonspecific amplification. While this does not indicate target contamination, it does suggest that your primers may be forming dimers under your reaction conditions. This can reduce amplification efficiency in experimental samples. Consider optimizing annealing temperature or redesigning primers.

3. How many NTC replicates should I include in a qPCR experiment?

For most qPCR experiments, include at least two NTC replicates per plate. For high-throughput or clinical applications, three replicates are recommended. The MIQE guidelines recommend including NTCs in duplicate or triplicate.

4. My NRT control shows amplification but my RNA was DNase-treated. What went wrong?

DNase treatment can fail for several reasons: insufficient DNase concentration, inadequate incubation time, or the presence of DNase inhibitors in the RNA preparation. Additionally, some DNase enzymes require specific buffer conditions that may not be compatible with your RNA extraction method. Consider using a different DNase protocol or verifying DNase activity with a positive control.

References and Further Reading

1. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. Available at: https://www.cdc.gov/labs/bmbl/index.html

   • Provides authoritative principles for risk assessment, containment, decontamination, and microbiological laboratory practice relevant to PCR setup and waste handling.

2. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. NIH Office of Science Policy. Available at: https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/

   • Establishes the institutional and biosafety framework for recombinant and synthetic nucleic acid research, including PCR-based experiments.

3. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. Available at: https://www.ncbi.nlm.nih.gov/books/

   • A searchable collection of authoritative biomedical books and methods references covering PCR principles, control strategies, and troubleshooting.

Related Articles

• How to Set Up a qPCR Plate Layout for Reproducible Results
• Understanding Positive Controls in PCR: Purpose, Selection, and Interpretation
• Contamination Control in PCR and qPCR: Sources, Prevention, and Decontamination
• Controls in qPCR: No Template Control, No Reverse Transcriptase Control, and Positive Control
• Template Quality Control for PCR and qPCR: Assessing DNA and RNA Integrity
• Understanding Ct Values in qPCR: What They Mean and How to Use Them